Uskent, N. Et Al. 2020. Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy. JOURNAL OF ONCOLOGY , vol.2020 .

Uskent, N., AYLA, Ş., Mandel, N. M., ÖZKAN, M., Teomete, M., Baloglu, H., ... Aydincer, C.(2020). Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy. JOURNAL OF ONCOLOGY , vol.2020.

Uskent, Necdet Et Al. "Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy," JOURNAL OF ONCOLOGY , vol.2020, 2020

Uskent, Necdet Et Al. "Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy." JOURNAL OF ONCOLOGY , vol.2020, 2020

Uskent, N. Et Al. (2020) . "Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy." JOURNAL OF ONCOLOGY , vol.2020.

@article{article, author={Necdet Uskent Et Al. }, title={Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy}, journal={JOURNAL OF ONCOLOGY}, year=2020}